TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/29/25 08:37 | 7/28/25 | ABSI | Absci Corp | Health | Biolab | Commercial Physical & Biologi | Busch Andreas | WA | O | Chief In | P | 152 | 3.04 | 0 | 50 | 18 | 327 | D | |||||||||||||||
11/12/20 17:05 | 11/9/20 | CYCN | Cyclerion Therapeutics, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Busch Andreas | MA | O | Chief In | P | 316 | 2.53 | 0 | 125 | 96 | 255 | D | ||||||||||||||
11/19/19 16:02 | 11/15/19 | CYCN | Cyclerion Therapeutics, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Busch Andreas | MA | O | Chief In | P | 228 | 1.82 | 0 | 125 | New | 125 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |